Essential hypertension
Conditions
Interventions
Observation Group of Primary hypertension:None
Sponsors
Peking University Shenzhen Hospital
Eligibility
Sex/Gender
All
Age
35 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Those aged 35 to 65 years old; 2. Patients diagnosed with essential hypertension, including those who are newly diagnosed with hypertension or are currently undergoing antihypertensive treatment; 3. Informed consent and voluntary participation in research.
Exclusion criteria
Exclusion criteria: 1.SBP>=190mmHg; 2. Those who have persistent atrial fibrillation or arrhythmia that affects the measurement of electronic blood pressure monitors; 3. Patients with combined cardiomyopathy (including hypertrophic cardiomyopathy and dilated cardiomyopathy), rheumatic heart disease, congenital heart disease, and severe valvular heart disease who need to undergo valve replacement during the study period; 4. Those with NYHA grade III or IV heart failure at the time of screening, or those who have been hospitalized due to the aggravation of chronic heart failure in the past 6 months; 5. Severe liver or kidney disease (alanine aminotransferase >= three times the upper limit of normal;) 6. Patients undergoing dialysis treatment or with an estimated glomerular filtration rate of less than 30ml/min/1.73m^2, or with a serum creatinine level greater than 2.5mg/dL[>221umol/L]; 7. Those with cognitive impairment, confusion or language communication disorders; 9. Those who are unable to upload blood pressure information or have no one to assist in uploading blood pressure information.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The proportion of time taken to reach the target systolic blood pressure (110<=SBP<130 mmHg); | — |
Countries
China
Contacts
Public ContactQuan Shuping
Peking University Shenzhen Hospital
Outcome results
None listed